STRR
Star Equity Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$10.62
+0.95%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 209.8M | 172.2M | 53.4M | 161.3M | 200.9M |
| Cost of Revenue | 122.9M | 93.5M | 42.3M | 81.1M | 101.7M |
| Gross Profit | 86.9M | 78.7M | 11.1M | 80.3M | 99.2M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 94.0M | 82.3M | 17.0M | 77.4M | 88.5M |
| General & Admin Expense | — | — | — | 73.8M | 84.7M |
| Selling & Marketing Expense | — | — | — | 3.6M | 3.8M |
| Other Expenses | — | — | 2.5M | 1.5M | 1.4M |
| Total Operating Expenses | 94.0M | 82.3M | 19.5M | 78.9M | 89.9M |
| Cost and Expenses | 216.9M | 175.8M | 61.8M | 160.0M | 191.6M |
| Operating Income (EBIT) | (7.1M) | (3.7M) | (8.4M) | 1.4M | 9.3M |
| Non-Operating | |||||
| Interest Income | 135.0K | 260.0K | 633.0K | 372.0K | 83.0K |
| Interest Expense | 13.0K | — | — | — | — |
| Net Interest Income | 122.0K | 260.0K | 633.0K | 372.0K | 83.0K |
| Other Non-Op Income/Expense | (288.0K) | (168.0K) | (1.8M) | 1.2M | 123.0K |
| Non-Operating Income (excl Interest) | 67.0K | 168.0K | 1.8M | (1.2M) | — |
| EBT (Pre-Tax Income) | (7.4M) | (3.9M) | (10.2M) | 2.6M | 9.5M |
| Income Tax Expense | 1.7M | 2.1M | 263.0K | 370.0K | 2.3M |
| Bottom Line | |||||
| Net Income | (9.1M) | (5.9M) | (10.4M) | 2.2M | 7.1M |
| Earnings from Cont. Ops | (9.1M) | (5.9M) | (10.4M) | 2.2M | 7.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (11.0M) | (6.7M) | (12.5M) | 2.2M | 7.1M |
| Per Share | |||||
| Basic EPS | ($3.06) | ($2.08) | ($3.97) | $0.53 | $2.37 |
| Diluted EPS | ($3.06) | ($2.08) | ($3.97) | $0.53 | $2.27 |
| Revenue Per Share | $56.63 | $53.83 | $16.97 | $39.08 | $66.73 |
| Shares | |||||
| Basic Shares Outstanding | 3.7M | 3.2M | 3.1M | 4.1M | 3.0M |
| Diluted Shares Outstanding | 3.7M | 3.2M | 3.1M | 4.1M | 3.1M |
| Profitability Metrics | |||||
| EBITDA | (5.0M) | (2.6M) | (6.6M) | 4.0M | 10.7M |
| D&A | 2.2M | 1.2M | 3.6M | 1.5M | 1.4M |
| EBIT | (7.2M) | (3.9M) | (10.2M) | 2.6M | 9.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026